Phase II Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Erlotinib (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 06 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 12 Jun 2014 Planned End Date changed from 1 Aug 2012 to 1 Jul 2015 as reported by ClinicalTrials.gov record.